Collectively, our data reveal a role for cardiac lymphatics in the resolution of inflammation after MI, in a process dependent on LYVE-1 and augmented by VEGF-C(C156S)–induced lymphangiogenesis. The gene discussed is VEGFC; the disease is myocardial infarction.